Royal Bank of Canada’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Buy |
7,694
+1,965
| +34% | +$25.5K | ﹤0.01% | 5264 |
|
|
2025
Q1 | $126K | Buy |
5,729
+2,405
| +72% | +$52.9K | ﹤0.01% | 4708 |
|
|
2024
Q4 | $89K | Sell |
3,324
-5,590
| -63% | -$150K | ﹤0.01% | 4937 |
|
|
2024
Q3 | $238K | Buy |
8,914
+1,341
| +18% | +$35.8K | ﹤0.01% | 4246 |
|
|
2024
Q2 | $136K | Buy |
7,573
+5,581
| +280% | +$100K | ﹤0.01% | 4679 |
|
|
2024
Q1 | $37K | Sell |
1,992
-12,092
| -86% | -$225K | ﹤0.01% | 5215 |
|
|
2023
Q4 | $154K | Buy |
14,084
+6,182
| +78% | +$67.6K | ﹤0.01% | 4785 |
|
|
2023
Q3 | $45K | Buy |
7,902
+2,738
| +53% | +$15.6K | ﹤0.01% | 5350 |
|
|
2023
Q2 | $40K | Buy |
5,164
+2,339
| +83% | +$18.1K | ﹤0.01% | 5430 |
|
|
2023
Q1 | $19K | Sell |
2,825
-1,547
| -35% | -$10.4K | ﹤0.01% | 5657 |
|
|
2022
Q4 | $39K | Buy |
4,372
+3,160
| +261% | +$28.2K | ﹤0.01% | 5555 |
|
|
2022
Q3 | $12K | Buy |
1,212
+194
| +19% | +$1.92K | ﹤0.01% | 5851 |
|
|
2022
Q2 | $8K | Sell |
1,018
-2,209
| -68% | -$17.4K | ﹤0.01% | 5993 |
|
|
2022
Q1 | $31K | Sell |
3,227
-12,425
| -79% | -$119K | ﹤0.01% | 5877 |
|
|
2021
Q4 | $239K | Buy |
15,652
+14,251
| +1,017% | +$218K | ﹤0.01% | 4641 |
|
|
2021
Q3 | $24K | Buy |
1,401
+557
| +66% | +$9.54K | ﹤0.01% | 6083 |
|
|
2021
Q2 | $18K | Buy |
+844
| New | +$18K | ﹤0.01% | 6113 |
|